Literature DB >> 17056140

The effects of ventricular asynchrony on myocardial perfusion.

Zenon S Kyriakides1, Athanase G Manolis, Theofilos M Kolettis.   

Abstract

Asynchronous depolarization and contraction sequence, secondary to intraventricular conduction defects or to permanent right ventricular apical pacing, is associated with adverse effects that may be clinically evident in the failing heart. Experimental and clinical studies have suggested that asynchronous ventricular contraction deteriorates left ventricular performance and induces unfavourable left ventricular remodelling. Although such contraction does not appear to affect resting coronary artery blood flow, it increases endomyocardial pressure during diastole and decreases regional myocardial perfusion in the interventricular septum. The magnitude of these effects may correlate with the duration of the asynchrony. Despite these detrimental effects, there is no evidence that ventricular asynchrony reduces collateral myocardial blood flow, myocardial oxygen consumption or cardiac efficiency, neither in patients with normal coronary arteries, nor in patients with coronary artery disease. Furthermore, in patients with acute ischaemic syndromes, ventricular asynchrony exerts a neutral effect on the ischaemic myocardium. Cardiac resynchronization therapy improves left ventricular systolic and diastolic function without an increase in myocardial oxygen consumption or energy cost. This therapy may decrease the inhomogeneity in regional oxidative metabolism, myocardial perfusion and cardiac efficiency. Further experimental and clinical studies are needed on this area.

Entities:  

Mesh:

Year:  2006        PMID: 17056140     DOI: 10.1016/j.ijcard.2006.03.091

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism.

Authors:  Abdulkadir Kırış; Cihangir Erem; Gülhanım Kırış; Mustafa Koçak; Omer Gedikli; Irfan Nuhoğlu; Merih Kutlu; Tuba Kaplan; Mustafa Gökçe; Sükrü Celik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  The role of biventricular pacing in the prevention and therapy of pacemaker-induced cardiomyopathy.

Authors:  Maya Guglin; S Serge Barold
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-01-06       Impact factor: 1.468

3.  Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy.

Authors:  Ying Xu; Dawn A Delfín; Jill A Rafael-Fortney; Paul M L Janssen
Journal:  J Appl Physiol (1985)       Date:  2010-12-02

4.  Role of coronary flow regulation and cardiac-coronary coupling in mechanical dyssynchrony associated with right ventricular pacing.

Authors:  Lei Fan; Ravi Namani; Jenny S Choy; Yousif Awakeem; Ghassan S Kassab; Lik Chuan Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-24       Impact factor: 4.733

5.  Hemodynamic changes in left anterior descending coronary artery and anterior interventricular vein during right ventricular apical pacing: a doppler ultrasound study in open chest beagles.

Authors:  Jing Lu; Wenhua Li; Ying Fu; Bin Long; Jie Shen; Li Su; Lixue Yin
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

6.  Assesment of myocardial ischemia by combination of tissue synchronisation imaging and dobutamine stress echocardiography.

Authors:  Muhammed Hakan Tas; Enbiya Aksakal; Yekta Gurlertop; Ziya Simsek; Fuat Gundogdu; Serdar Sevimli; Eftal Murat Bakirci; Sule Karakelleoglu
Journal:  Korean Circ J       Date:  2013-06-30       Impact factor: 3.243

7.  Endothelin-B Receptors and Left Ventricular Dysfunction after Regional versus Global Ischaemia-Reperfusion in Rat Hearts.

Authors:  Sofia-Iris Bibli; Eleni V Toli; Agapi D Vilaeti; Varnavas C Varnavas; Giannis G Baltogiannis; Apostolos Papalois; Zenon S Kyriakides; Theofilos M Kolettis
Journal:  Cardiol Res Pract       Date:  2012-07-12       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.